Emma Guttman
Clinical trials sponsored by Emma Guttman, explained in plain language.
-
Experimental drug aims to halt scarring hair loss
Disease control CompletedThis pilot study tests an experimental drug called ritlecitinib in people with cicatricial alopecia, a type of hair loss where hair follicles are permanently destroyed and replaced by scar tissue. The drug works by blocking certain enzymes involved in inflammation. Researchers wi…
Phase: PHASE2 • Sponsor: Emma Guttman • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New drug shows promise for irreversible hair loss
Disease control CompletedThis study tested a new drug (PF-06700841) in 51 adults with cicatricial alopecia, a type of hair loss that destroys hair follicles and leaves scars. The main goals were to check the drug's safety and see how it affects certain genes in the skin and blood. Researchers hope this w…
Phase: PHASE2 • Sponsor: Emma Guttman • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC